Dysregulation of Kynurenine Pathway and Potential Dynamic Changes of Kynurenine in Schizophrenia: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of Kynurenine Pathway and Potential Dynamic Changes of Kynurenine in Schizophrenia: A Systematic Review and Meta-Analysis
Authors
Keywords
Schizophrenia, Kynurenine pathway, Kynurenic acid, Antipsychotic treatment, Tryptophan
Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-26
DOI
10.1016/j.neubiorev.2021.01.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
- (2020) David Phenis et al. PSYCHOPHARMACOLOGY
- Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
- (2020) Gayathri Sundaram et al. Journal of Neuroinflammation
- The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
- (2019) Bashkim Kadriu et al. MOLECULAR PSYCHIATRY
- Schizophrenia
- (2019) Stephen R. Marder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study
- (2018) Bing Cao et al. AMINO ACIDS
- Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis
- (2018) Bing Cao et al. JOURNAL OF AFFECTIVE DISORDERS
- Kynurenine is correlated with IL-1β in plasma of schizophrenia patients
- (2018) Helena P. G. Joaquim et al. JOURNAL OF NEURAL TRANSMISSION
- Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia
- (2018) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia
- (2018) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis
- (2018) Liisa Leppik et al. Frontiers in Psychiatry
- IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s disease: Systematic Review and Meta-Analysis
- (2018) Ada Ng et al. Scientific Reports
- Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid
- (2017) Buranee Kanchanatawan et al. MOLECULAR NEUROBIOLOGY
- Genetic insights into the neurodevelopmental origins of schizophrenia
- (2017) Rebecca Birnbaum et al. NATURE REVIEWS NEUROSCIENCE
- The kynurenine pathway and parasitic infections that affect CNS function
- (2017) Nicholas H. Hunt et al. NEUROPHARMACOLOGY
- Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior
- (2017) Francesca M. Notarangelo et al. NEUROPHARMACOLOGY
- The kynurenine pathway and the brain: Challenges, controversies and promises
- (2017) Robert Schwarcz et al. NEUROPHARMACOLOGY
- Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia
- (2017) Kinga Szymona et al. NEUROTOXICITY RESEARCH
- Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
- (2017) Eric Plitman et al. SCHIZOPHRENIA BULLETIN
- Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia
- (2017) Bridget J. Shovestul et al. SCHIZOPHRENIA RESEARCH
- Serum kynurenic acid is reduced in affective psychosis
- (2017) B E Wurfel et al. Translational Psychiatry
- Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments
- (2017) Maju Mathew Koola et al. SCHIZOPHRENIA RESEARCH
- TDO as a therapeutic target in brain diseases
- (2016) Cheng-Peng Yu et al. METABOLIC BRAIN DISEASE
- Tryptophan Metabolism and White Matter Integrity in Schizophrenia
- (2016) Joshua Chiappelli et al. NEUROPSYCHOPHARMACOLOGY
- Simultaneous determination of amino acids and neurotransmitters in plasma samples from schizophrenic patients by hydrophilic interaction liquid chromatography with tandem mass spectrometry
- (2015) Diego Soares Domingues et al. JOURNAL OF SEPARATION SCIENCE
- Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
- (2015) Francesco Fazio et al. Scientific Reports
- Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
- (2014) Carson Ka-Lok Lo et al. BMC Medical Research Methodology
- Reduction of Brain Kynurenic Acid Improves Cognitive Function
- (2014) R. Kozak et al. JOURNAL OF NEUROSCIENCE
- Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients
- (2014) Takeshi Fukushima et al. PLoS One
- Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor
- (2014) H.-Q. Wu et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia--Time to Commit to Policy Change
- (2014) W. W. Fleischhacker et al. SCHIZOPHRENIA BULLETIN
- Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia
- (2014) Ikwunga Wonodi et al. SCHIZOPHRENIA RESEARCH
- Stress-Induced Increase in Kynurenic Acid as a Potential Biomarker for Patients With Schizophrenia and Distress Intolerance
- (2014) Joshua Chiappelli et al. JAMA Psychiatry
- A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study
- (2014) S Koike et al. Translational Psychiatry
- Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report
- (2013) Eva Z Reininghaus et al. BIPOLAR DISORDERS
- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Prenatal inhibition of the tryptophan–kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus
- (2013) Caroline M. Forrest et al. BRAIN RESEARCH
- Targeted Deletion of Kynurenine 3-Monooxygenase in Mice
- (2013) Flaviano Giorgini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: A meta-analysis of case–control studies
- (2013) Annelies Brouwer et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2012) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
- (2011) Ikwunga Wonodi ARCHIVES OF GENERAL PSYCHIATRY
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients
- (2011) A.M. Myint et al. BRAIN BEHAVIOR AND IMMUNITY
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls
- (2011) Maria Holtze JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner
- (2011) A. J. Ramsey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration
- (2010) Myung Lee et al. PSYCHIATRY RESEARCH
- Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
- (2010) K. V. Sathyasaikumar et al. SCHIZOPHRENIA BULLETIN
- Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
- (2010) K. R. Linderholm et al. SCHIZOPHRENIA BULLETIN
- Cytokine Changes and Tryptophan Metabolites in Medication-Naïve and Medication-Free Schizophrenic Patients
- (2009) Yong-Ku Kim et al. NEUROPSYCHOBIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Kynurenine pathway in psychosis: evidence of increased tryptophan degradation
- (2008) S Barry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder
- (2008) Christine L. Miller et al. NEUROCHEMISTRY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now